Sort by
Medicine and Dentistry
Absorptiometry
9%
Adipocyte
55%
Adiponectin
31%
Adipose Tissue
38%
Adverse Event
11%
Antidiabetic Agent
12%
Body Weight
16%
Bone
20%
Calcium Excretion
9%
Cancer
17%
Cannabinoid 1 Receptor
9%
Cardiovascular Disease
20%
Cardiovascular System
19%
Cell Communication
11%
Cell Function
19%
Cells
65%
Chemotherapeutic Agent
9%
Chronic Kidney Disease
19%
Clinical Trial
15%
Combination Therapy
42%
Connexin 43
27%
Cotransporter
11%
Creatine Phosphate
9%
Dapagliflozin
81%
Development
16%
Diabetes
16%
Diabetes Mellitus
10%
Drug
9%
Empagliflozin
9%
Exenatide
21%
Fat
10%
Fine-Needle Aspiration
11%
Finerenone
13%
Gap Junction Protein
20%
Gene
11%
Glucagon
18%
Glucagon Like Peptide 1
12%
Glucagon-Like Peptide-1 Agonist
29%
Gluconeogenesis
42%
Glucose
77%
Glucose Tolerance
15%
Glucose Uptake
18%
Glucosuria
24%
Glycemic Control
17%
Gonadorelin Agonist
9%
Health Outcomes
10%
Heart
19%
Heart Function
13%
Hepatocyte Nuclear Factor 4
9%
Human Study
9%
Hypercalcaemia
12%
Hyperglycemia
19%
Hyperleptinemia
11%
Hypoglycemia
10%
Infusion
9%
Inpatient
38%
Insulin
43%
Insulin Release
28%
Insulin Resistance
39%
Insulin Sensitivity
34%
Iron
9%
Kidney
12%
Leptin
29%
Lifespan
15%
Lipid Diet
16%
Male
10%
Maturity Onset Diabetes of the Young
100%
Meta-Analysis
9%
Metabolism
10%
Microinjection
9%
Mineralocorticoid Antagonist
12%
Musculoskeletal Health
12%
Obesity
35%
Oral Glucose Tolerance Test
14%
Osteoclast
15%
Osteoclast Differentiation Factor
9%
Osteocyte
15%
Paget's Disease
16%
Patient
81%
Patient with Type 1 Diabetes
9%
Patient with Type 2 Diabetes
24%
Peroxisome Proliferator Activated Receptor
9%
Pheochromocytoma
9%
Physical Activity
9%
Pioglitazone
19%
Placebo
38%
Placebo
9%
Plasma
46%
Primary Hyperparathyroidism
9%
Regulatory Mechanism
15%
Resistance Training
10%
Sarcopenia
14%
Semaglutide
9%
Serositis
12%
Therapeutic Procedure
59%
Tissues
18%
Type 2 Diabetes
16%
Vascular Disease
9%
Weight Loss
11%
White Adipose Tissue
13%
Biochemistry, Genetics and Molecular Biology
Acetyl-CoA Synthetase
9%
Adenosine Triphosphate
9%
Adipocyte
47%
Adiponectin
12%
Adrenergic Receptor
9%
Alternative Splicing
9%
Apoptosis
6%
Arginine
9%
Bile Acid
9%
Bile Acid Synthesis
9%
Calcium Excretion
9%
Calcium Urine Level
9%
Cancer Cell
5%
Chicken
19%
Connexin
58%
Cotransporter
6%
Dapagliflozin
15%
Development
7%
Dimethyl Sulfoxide
9%
Drive
5%
Drug Efficacy
9%
Electric Potential
8%
Excretion
8%
Fat
17%
FGF21
7%
Free Fatty Acids
12%
Galactose
9%
Gluconeogenesis
14%
Glucose
37%
Glucose Blood Level
8%
Glucose Homeostasis
5%
Glucose Metabolism
7%
Hepatic Stellate Cell
9%
Hepatocyte Nuclear Factor 4
9%
Human Study
9%
Hyaluronan
9%
Immunity
6%
Insulin
9%
Insulin Release
20%
Insulin Resistance
13%
Insulin Sensitivity
5%
Iron
9%
Knockout Mouse
17%
Lifespan
9%
Lipid
5%
Lipid Droplet
9%
Lipid Metabolism
15%
Lipogenesis
13%
Lipolysis
6%
Lysozyme
7%
Marker Gene
9%
Metabolic Pathway
8%
Microinjection
9%
Mitochondrial Respiration
9%
Mouse
55%
Mouse Model
7%
Nested Gene
9%
Ossification
11%
Ossification
5%
Osteocyte
21%
Osteolysis
8%
Peptide
11%
Peroxisome Proliferator-Activated Receptor Gamma
9%
Phenotype
5%
Physical Activity
9%
Pressure
5%
Prostaglandin E2
9%
Prostaglandin E2
9%
Protein
5%
Protein Kinase
9%
Pyruvate Kinase
9%
Regulatory Mechanism
6%
Retrovirus
9%
Serine
9%
Stromal Cell
9%
Syntaxin
9%
Titer
9%
Transgenic Mouse
5%
Transmembrane Protein
6%
Vascularization
13%
Wound Healing
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acetate Coenzyme A Ligase
9%
Adenosine Triphosphate
9%
Adiponectin
18%
Adverse Event
7%
Alzheimer's Disease
9%
Amyloid Protein
9%
Antidiabetic Agent
7%
Bile Acid
9%
Breast Cancer
9%
Connexin 43
9%
Dapagliflozin
17%
Diethylstilbestrol
6%
Dimethyl Sulfoxide
9%
Diseases
9%
Diseases
6%
Drug
7%
Empagliflozin
19%
Estrogen
5%
Finerenone
9%
Gap Junction Protein
19%
Glitazone Derivative
8%
Glucagon Like Peptide 1 Receptor Agonist
9%
Glucose
11%
Hepatocyte Nuclear Factor 4
9%
Hyperglycemia
5%
Hyperkalemia
9%
Hyperleptinemia
9%
Insulin
10%
Insulin Resistance
14%
Leptin
29%
Leptin Deficiency
5%
Linagliptin
9%
Liraglutide
9%
Liver Injury
9%
Luciferase
5%
Metastasis
5%
Mouse
21%
Muscone
9%
Non Insulin Dependent Diabetes Mellitus
31%
Nonalcoholic Fatty Liver
9%
Obesity
15%
Osteoporosis
5%
Osteosarcoma
9%
Peroxisome Proliferator Activated Receptor
9%
Pioglitazone
19%
Placebo
9%
Placebo
6%
Prasterone
9%
Primary Hyperparathyroidism
9%
Saxagliptin
5%
Semaglutide
19%
Semaglutide
9%
Synthetase
9%
Vascular Disease
9%